02/24
Headlines

Finance

Momentum Stocks :ChinaCache (NASDAQ:CCIH), DR (NYSE:DHI), New England Realty Associates (NYSEMKT:NEN), Jack Henry & Associates Inc. (NASDAQ:JKHY), Real Goods (NASDAQ:RGSE

Kristen Barton02 mins

ChinaCache International Holdings Ltd. (Nasdaq:CCIH), the leading total solutions provider of Internet content and application delivery services in China, today announced its unaudited condensed consolidated financial results for the second quarter of 2014. ChinaCache International Holdings Ltd. (NASDAQ:CCIH) belongs to Technology sector. Its net profit margin is -3.10% and weekly performance is 6.92%. On last…

Read More

Today’s Watch List: Dresser-Rand (NYSE:DRC), Corning (NYSE:GLW), Caterpillar Inc. (NYSE:CAT), First Solar (NASDAQ:FSLR), Medical Properties Trust (NYSE:MPW)

Mark DeFrance02 mins

Analysts at Guggenheim upgraded shares of Dresser-Rand Group from a “neutral” rating to a “buy” rating in a research note on Thursday, August 14th. Dresser-Rand Group Inc. (NYSE:DRC) belongs to Industrial Goods sector. Its net profit margin is 4.60% and weekly performance is 6.53%. On last trading day company shares ended up $68.20. Dresser-Rand Group…

Read More

Active Stocks to Watch: Leidos Holdings (NYSE:LDOS), Sony (NYSE:SNE), Opko Health (NYSE:OPK), FedEx Corporation (NYSE:FDX), Alpha Natural Resources, Inc. (NYSE:ANR)

Chris Lewis02 mins

Leidos Holdings Inc. (NYSE: LDOS), a scientific, engineering, and technology applications company, is scheduled to hold its second quarter 2015 earnings conference call with investors to discuss operations and financial results on Tuesday, September 9, 2014 beginning at 8 a.m. Eastern.  The company plans to issue its second quarter fiscal year 2015 earnings press release…

Read More

Biotech Stock Update: Biotech Stock Gilead Scores Legal Victory Over Roche for Sovaldi

Richard Atkins02 mins

Shares of Gilead Sciences (GILD) gained 3.25% to close the trading session on Aug 15 at $99.45 per share following the favorable verdict by an arbitration panel in a patent infringement case with Roche (RHHBY). The tussle was regarding Gilead’s blockbuster hepatitis C drug, Sovaldi (sofosbuvir). Gilead received further encouraging news on Sovaldi when U.K.’s…

Read More